Tert-butyl 5-oxo-2,6-diazaspiro[3.5]nonane-2-carboxylate
Structure Info
- Chemspace ID
- CSSB00102708302 (In-Stock Building Blocks)
- CAS
- 2138094-74-1
- MFCD
- MFCD31612661
- IUPAC Name
- tert-butyl 5-oxo-2,6-diazaspiro[3.5]nonane-2-carboxylate
- Mol formula
- C12H20N2O3
- Mol weight
- 240 Da
- Catalog Number(s)
- 204828, AG024UI7, AR024V77, ArZ-UP194785, ArZ-UP418125, BB4LS-EN300-1197987, BBLS00102708302, BBV-118201493, BD01426747, BJ85191, CSC102708302, CSCR01623158510, EN300-1197987, NKD09474, PBU7845, ST024VYZ, TX024VNV, X184324, Y3157711, Z3819664216, ZX-NM238060, ZX-NM283641, ZXC392891, bbls00102708302, m282070____22252018____26287130
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 0.53
- Heavy atoms count
- 17
- Rotatable bond count
- 2
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.833
- Polar surface area (Å)
- 59
- Hydrogen bond acceptors count
- 2
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSSB00102708302
Items Overall 10 items from 3 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 50 mg | 245.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 100 mg | 366.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 50 mg | 245.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 100 mg | 366.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 250 mg | 524.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 500 mg | 824.00 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 50 mg | 336.60 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 100 mg | 477.40 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 250 mg | 660.00 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 500 mg | 1,007.60 | |
Description: tert-butyl 5-oxo-2,6-diazaspiro[3.5]nonane-2-carboxylate; CAS: 2138094-74-1 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire